Identifying the Optimal IMT Dose in ICU — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Identifying the Optimal IMT Dose in ICU — Stella

Recruiting

Back to Difficult to Wean, Mechanically Ventilated Patients With a Tracheostomy trials

Trial locations(1 site)

United Kingdom

Royal Brompton and Harefield Hospitals, Marlow

Key details

Sponsor

Royal Brompton & Harefield NHS Foundation Trust

Enrollment target

~40 participants

Started

November 2025

Primary completion

January 2027

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov